Oncology & Cancer

Checkpoint inhibitor shrinks advanced squamous cell skin cancer

Clinical trials show that an immune checkpoint inhibitor shrinks the tumors of nearly half of patients with an incurable, advanced form of a common skin cancer, an international team led by a researcher at The University ...

Oncology & Cancer

New biomarker identified for early diagnosis of lung cancer

High levels of cytoskeleton-associated protein 4 (CKAP4) have been identified in the blood of patients with lung cancer. In a novel study in The American Journal of Pathology investigators found that CKAP4 levels were significantly ...

Surgery

Proactive swallowing rehab program helpful in phalangeal CA

(HealthDay)—A proactive speech and language pathology (SLP) program is beneficial for patients with head and neck squamous cell carcinoma (HNSCC), according to a study published online April 19 in JAMA Otolaryngology-Head ...

Surgery

Most smokers with head and neck cancer have tried to quit

(HealthDay)—Most active smokers with head and neck squamous cell carcinoma (HNSCC) have made one or more quit attempts, according to a study published online April 12 in JAMA Otolaryngology-Head & Neck Surgery.

Oncology & Cancer

Hydrochlorothiazide tied to non-melanoma skin cancer risk

(HealthDay)—Use of the diuretic hydrochlorothiazide is associated with a substantially increased risk of non-melanoma skin cancer, according to a study published in the April issue of the Journal of the American Academy ...

page 16 from 36